Hanan M. Refaat

845 total citations
22 papers, 704 citations indexed

About

Hanan M. Refaat is a scholar working on Organic Chemistry, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Hanan M. Refaat has authored 22 papers receiving a total of 704 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Organic Chemistry, 7 papers in Molecular Biology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Hanan M. Refaat's work include Synthesis and biological activity (16 papers), Synthesis and Characterization of Heterocyclic Compounds (8 papers) and Synthesis and Biological Evaluation (8 papers). Hanan M. Refaat is often cited by papers focused on Synthesis and biological activity (16 papers), Synthesis and Characterization of Heterocyclic Compounds (8 papers) and Synthesis and Biological Evaluation (8 papers). Hanan M. Refaat collaborates with scholars based in Egypt, Saudi Arabia and United States. Hanan M. Refaat's co-authors include Mohamed Hagras, Nasser S. M. Ismail, Asmaa E. Kassab, Manal M. Kandeel, Afaf El‐Malah, Tamer M. Abdelghany, Kamilia M. Amin, Fadi M. Awadallah, Hanan H. Kadry and Mostafa M. Ghorab and has published in prestigious journals such as SHILAP Revista de lepidopterología, RSC Advances and European Journal of Medicinal Chemistry.

In The Last Decade

Hanan M. Refaat

22 papers receiving 671 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hanan M. Refaat Egypt 14 590 173 69 61 39 22 704
Fatma A.F. Ragab Egypt 11 513 0.9× 216 1.2× 77 1.1× 46 0.8× 55 1.4× 17 640
Sravani Sana India 14 562 1.0× 255 1.5× 57 0.8× 27 0.4× 38 1.0× 18 668
Ahsan Ahmed Khan India 8 639 1.1× 219 1.3× 92 1.3× 76 1.2× 44 1.1× 9 771
Zulphikar Ali India 9 657 1.1× 241 1.4× 99 1.4× 78 1.3× 51 1.3× 12 802
Manolis A. Fousteris Greece 16 341 0.6× 273 1.6× 97 1.4× 39 0.6× 40 1.0× 40 590
María Kimatrai Salvador Italy 18 686 1.2× 251 1.5× 87 1.3× 53 0.9× 46 1.2× 23 815
Malini Ravi United States 10 231 0.4× 178 1.0× 74 1.1× 77 1.3× 18 0.5× 10 416
Muralidhar R. Mallireddigari United States 12 457 0.8× 212 1.2× 87 1.3× 27 0.4× 36 0.9× 14 646
Stephen T. Wrobleski United States 13 384 0.7× 196 1.1× 37 0.5× 61 1.0× 14 0.4× 16 555
Helmy I. Heiba Egypt 18 691 1.2× 323 1.9× 75 1.1× 24 0.4× 35 0.9× 36 780

Countries citing papers authored by Hanan M. Refaat

Since Specialization
Citations

This map shows the geographic impact of Hanan M. Refaat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hanan M. Refaat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hanan M. Refaat more than expected).

Fields of papers citing papers by Hanan M. Refaat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hanan M. Refaat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hanan M. Refaat. The network helps show where Hanan M. Refaat may publish in the future.

Co-authorship network of co-authors of Hanan M. Refaat

This figure shows the co-authorship network connecting the top 25 collaborators of Hanan M. Refaat. A scholar is included among the top collaborators of Hanan M. Refaat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hanan M. Refaat. Hanan M. Refaat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Mandour, Asmaa A., Eslam B. Elkaeed, Mohamed Hagras, Hanan M. Refaat, & Nasser S. M. Ismail. (2023). Virtual Screening Approach for the Discovery of Selective 5α-Reductase Type II Inhibitors for Benign Prostatic Hyperplasia Treatment. Future Medicinal Chemistry. 15(23). 2149–2163. 3 indexed citations
3.
Mandour, Asmaa A., Ibrahim F. Nassar, Wael A. El‐Sayed, et al.. (2022). Synthesis, biological evaluation, and in silico studies of new CDK2 inhibitors based on pyrazolo[3,4- d ]pyrimidine and pyrazolo[4,3- e ][1,2,4]triazolo[1,5- c ]pyrimidine scaffold with apoptotic activity. Journal of Enzyme Inhibition and Medicinal Chemistry. 37(1). 1957–1973. 31 indexed citations
4.
Ismail, Nasser S. M., et al.. (2021). Medicinal attributes of pyridine scaffold as anticancer targeting agents. SHILAP Revista de lepidopterología. 7(1). 61 indexed citations
5.
Hagras, Mohamed, Asmaa A. Mandour, Eslam B. Elkaeed, et al.. (2021). Design, synthesis, docking study and anticancer evaluation of new trimethoxyphenyl pyridine derivatives as tubulin inhibitors and apoptosis inducers. RSC Advances. 11(63). 39728–39741. 11 indexed citations
6.
Refaat, Hanan M., et al.. (2020). Versatile mechanisms of 2-substituted benzimidazoles in targeted cancer therapy. SHILAP Revista de lepidopterología. 6(1). 21 indexed citations
7.
8.
Awadallah, Fadi M., et al.. (2018). Design, Synthesis and Molecular Modeling Study for Some New 2-Substituted Benzimidazoles as Dual Inhibitors for VEGFR-2 and c-Met. Future Medicinal Chemistry. 10(5). 493–509. 16 indexed citations
9.
Refaat, Hanan M., et al.. (2016). Application of Resin-Bound Reagents for the Synthesis of Benzimidazole Derivatives. Journal of Chemical Research. 40(8). 478–485. 1 indexed citations
10.
Kandeel, Manal M., et al.. (2014). Synthesis, anticancer activity and effects on cell cycle profile and apoptosis of novel thieno[2,3-d]pyrimidine and thieno[3,2-e] triazolo[4,3-c]pyrimidine derivatives. European Journal of Medicinal Chemistry. 90. 620–632. 47 indexed citations
11.
Ghorab, Mostafa M., et al.. (2012). Anticancer and radiosensitizing evaluation of some new pyranothiazole-Schiff bases bearing the biologically active sulfonamide moiety. European Journal of Medicinal Chemistry. 53. 403–407. 32 indexed citations
12.
Kandeel, Manal M., et al.. (2012). SYNTHESIS OF EFFECTIVE ANTICANCER THIENO (2,3-d) PYRIMIDINE-4-ONES AND THIENO (3,2-e)TRIAZOLO(4,3-c)PYRIMIDINES Research Article. 1 indexed citations
13.
Kandeel, Manal M., et al.. (2012). Synthesis of Potent Anticancer Thieno[2,3-d]Pyrimidine Derivatives. Journal of Chemical Research. 36(5). 266–275. 9 indexed citations
14.
Kandeel, Manal M., et al.. (2012). Synthesis of Thieno[2,3-d]Pyrimidines, Thieno[2,3-d]Triazinones and Thieno[2,3-e]Diazepinones of Anticipated Anti-Cancer Activity. Journal of Chemical Research. 36(2). 105–110. 16 indexed citations
15.
Refaat, Hanan M., et al.. (2011). Synthesis and antiinflammatory activity of certain benzothieno[3,2-d][1,2,4]triazolo[4,3-b] pyridazine derivatives. Medicinal Chemistry Research. 21(10). 3146–3153. 1 indexed citations
16.
Refaat, Hanan M.. (2010). Synthesis and anticancer activity of some novel 2-substituted benzimidazole derivatives. European Journal of Medicinal Chemistry. 45(7). 2949–2956. 216 indexed citations
17.
18.
Refaat, Hanan M., et al.. (2007). Synthesis and anti-inflammatory activity of certain piperazinylthienylpyridazine derivatives. Archives of Pharmacal Research. 30(7). 803–811. 24 indexed citations
19.
Refaat, Hanan M., et al.. (2007). Synthesis and Antimicrobial Activity of Novel Quinoxaline Derivatives. Journal of the Chinese Chemical Society. 54(2). 469–478. 38 indexed citations
20.
Refaat, Hanan M., et al.. (2004). Synthesis and antimicrobial activity of certain novel quinoxalines. Archives of Pharmacal Research. 27(11). 1093–1098. 103 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fatma A.F. Ragab Breakdown of academic impact, for papers by Sravani Sana Breakdown of academic impact, for papers by Ahsan Ahmed Khan Breakdown of academic impact, for papers by Zulphikar Ali Breakdown of academic impact, for papers by Manolis A. Fousteris Breakdown of academic impact, for papers by María Kimatrai Salvador Breakdown of academic impact, for papers by Malini Ravi Breakdown of academic impact, for papers by Muralidhar R. Mallireddigari Breakdown of academic impact, for papers by Stephen T. Wrobleski Breakdown of academic impact, for papers by Helmy I. Heiba
Rankless by CCL
2026